PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25311380-0	2015	PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.	repaglinide	37-48	peroxisome proliferator activated receptor delta	Homo sapiens	0-5	
25311380-4	2015	However, little is known about the impacts of PPARD genetic polymorphism on the efficacy of repaglinide.	repaglinide	92-103	peroxisome proliferator activated receptor delta	Homo sapiens	46-51	
25311380-5	2015	Therefore, the current study was designed to investigate the associations of PPARD rs2016520 polymorphism with type 2 diabetes mellitus (T2DM) susceptibility and repaglinide therapeutic efficacy in Chinese Han T2DM patients.	repaglinide	162-173	peroxisome proliferator activated receptor delta	Homo sapiens	77-82	
25311380-11	2015	These findings suggest that PPARD rs2016520 polymorphism might influence the therapeutic effect of repaglinide rather than T2DM susceptibility in Chinese Han T2DM patients.	repaglinide	99-110	peroxisome proliferator activated receptor delta	Homo sapiens	28-33